International Patent: NOVEL RNA-GUIDED NUCLEASES AND NUCLEIC ACID TARGETING SYSTEMS COMPRISING SUCH RNA-GUIDED NUCLEASES

GENEVA, July 6 -- UCB BIOPHARMA SRL filed a patent application (EP2025/088577) for “NOVEL RNA-GUIDED NUCLEASES AND NUCLEIC ACID TARGETING SYSTEMS COMPRISING SUCH RNA-GUIDED NUCLEASES”. With publication no. WO/2026/139426, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 9/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....